Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Improving brain and muscle imaging techniques using magnetic resonance spectroscopy

Official title: Development of Magnetic Resonance Spectroscopic Imaging Techniques for Imaging Metabolites in Human Brain and Muscle

Run by National Institutes of Health Clinical Center (CC) · NCT01266577 · Data updated 2026-11-12

This study is trying to improve brain and muscle imaging techniques to better understand brain chemistry in healthy adults, which could help develop new treatments for mental health conditions.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment300 (estimated)
SponsorNational Institutes of Health Clinical Center (CC)
NIH
Locations1 site (Bethesda, Maryland)
StatusRecruiting
StartedJanuary 27, 2011
Main results expectedOctober 23, 2027
Study endsOctober 23, 2027
Registry record updatedNovember 6, 2026
Trial IDNCT01266577 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are healthy individuals aged 18 to 65 who can provide informed consent.

Probably not a fit

Patients with current psychiatric diagnoses or significant medical conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to enhance and develop magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) techniques to better visualize and measure brain metabolites and activity. By focusing on healthy volunteers aged 18 to 65, researchers will implement and optimize existing MRS methods while also creating new techniques for brain and muscle applications. Participants will undergo a thorough screening process followed by scanning sessions at the National Institutes of Health Clinical Center. The goal is to advance the understanding of brain chemistry, which could aid in the development of treatments for psychiatric conditions.

Why it matters

Potential benefit: If successful, this research could lead to improved diagnostic tools for understanding brain metabolism and potentially developing new treatments for mental illnesses.

How similar studies have gone: Other studies have shown promise in using magnetic resonance spectroscopy for brain imaging, making this approach both relevant and potentially impactful.

Who can join: the full rules

Show full inclusion / exclusion criteria
* INCLUSION CRITERIA:
* 18-65 years of age
* able to give written informed consent
* healthy based on medical history and physical exam
* enrolled in Protocol 01-M-0254 or Protocol 17-M-0181

EXCLUSION CRITERIA:

* Any current Axis 1 diagnosis
* Clinically significant laboratory abnormalities
* Positive HIV test
* Metallic foreign bodies that would be affected by the magnetic resonance imaging (MRI) magnet, or fear of enclosed spaces likely to make the subject unable to undergo an MRI scan.
* History of neurological illness or injury with the potential to affect study data interpretation, such as multiple sclerosis, Parkinson s disease, seizure disorder or traumatic brain injury
* Inability to lie flat on camera bed for about two and a half hours
* Pregnant or breastfeeding
* Current substance use disorder based on DSM-5
* NIMH employees and staff and their immediate family members will be excluded from the study per NIMH policy.

Where it's running

  • National Institutes of Health Clinical Center
    Bethesda, Maryland, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.